Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 1306 AL 1320

The high frequency of periodic limb movements in patients with Lewy body dementia

Hibi S, Yamaguchi Y, Umeda-Kameyama Y, Yamamoto H, Iijima K, Momose T, Akishita M, Ouchi Y.

J Psychiatr Res. 2012 Dec;46(12):1590-4. doi: 10.1016/j.jpsychires.2012.07.007. Epub 2012 Jul 25.

Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research

Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, Nihei Y, Nabetani A, Ishikawa F, Arai Y, Hirose N, Okano H, Suzuki N.

PLoS One. 2012;7(7):e41572. doi: 10.1371/journal.pone.0041572. Epub 2012 Jul 25.

Limbic and nigral Lewy bodies and Alzheimer's disease pathology mimicking progressive supranuclear palsy in a 75-year-old man with preserved cardiac uptake of MIBG

Kasahata N, Uchihara T, Orimo S, Nakamura A, Makita Y.

J Alzheimers Dis. 2012;32(4):889-94. doi: 10.3233/JAD-2012-120445.

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia

Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, Nacmias B, Pasquier F, Popescu BO, Rektorova I, Religa D, Rusina R, Rossor M, Schmidt R, Stefanova E, Warren JD, Scheltens P; EFNS Scientist Panel on Dementia and Cognitive Neurology.

Eur J Neurol. 2012 Sep;19(9):1159-79. doi: 10.1111/j.1468-1331.2012.03784.x.

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Sáez-Valero J, Saka E, Urbani A, Vanmechelen E, Verbeek M, Visser PJ, Teunissen C.

Biomark Med. 2012 Aug;6(4):419-30. doi: 10.2217/bmm.12.46.

Atypical motor and behavioral presentations of Alzheimer disease: a case-based approach

Duker AP, Espay AJ, Wszolek ZK, Rademakers R, Dickson DW, Kelley BJ.

Neurologist. 2012 Sep;18(5):266-72. doi: 10.1097/NRL.0b013e3182675376.

Neuropsychological assessment of driving safety risk in older adults with and without neurologic disease

Anderson SW, Aksan N, Dawson JD, Uc EY, Johnson AM, Rizzo M.

J Clin Exp Neuropsychol. 2012;34(9):895-905. doi: 10.1080/13803395.2011.630654. Epub 2012 Sep 3.

Inflammation and neurodegeneration: the story 'retolled'

Drouin-Ouellet J, Cicchetti F.

Trends Pharmacol Sci. 2012 Oct;33(10):542-51. doi: 10.1016/j.tips.2012.07.002. Epub 2012 Aug 31.

Target-based selection of flavonoids for neurodegenerative disorders

Jones QR, Warford J, Rupasinghe HP, Robertson GS.

Trends Pharmacol Sci. 2012 Nov;33(11):602-10. doi: 10.1016/j.tips.2012.08.002. Epub 2012 Sep 12.

[Clinicopathologic findings of argyrophilic-grain dementia in a case of mild cognitive impairment converting to dementia]

Iwasaki Y, Mori K, Ito M, Tatsumi S, Mimuro M, Yoshida M.

Rinsho Shinkeigaku. 2012;52(9):660-5. doi: 10.5692/clinicalneurol.52.660.

Pharmacological treatment of dementia

Schwarz S, Froelich L, Burns A.

Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2.

Poor insight into memory impairment in patients with Huntington disease

Sitek EJ, Sołtan W, Robowski P, Schinwelski M, Wieczorek D, Sławek J.

Neurol Neurochir Pol. 2012 Jul-Aug;46(4):318-25. doi: 10.5114/ninp.2012.30262.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias